FDA

News

Indivior's once-monthly schizophrenia injection gets US gree...

Regulators authorities in the US have approved Indivior’s long-acting injectable treatment for adults with schizophrenia.

News

FDA refuses to approve Insys opioid painkiller

The US regulators have rejected Insys Therapeutics' opioid-based painkiller because of concerns about its safety.

News

Bayer hits back at Netflix medical device documentary

Bayer has issued a robust defence of Essure after the birth control implant was featured in The Bleeding Edge, a Netflix documentary about the medical devices industry.

Partner Content

Partner Content

FDA releases Biosimilar Action Plan: Hear more at Biosimilar...

Biosimilars USA conference information

News

Janssen HIV Symtuza darunavir cobicistat emtricitabine tenofovir alafenamide

FDA approves Janssen's HIV combination Symtuza

Janssen has won US approval for its once-daily HIV pill Symtuza (D/C/F/TAF), which it hopes will improve patient adherence and resistance to treatment.

Events